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INTRODUCTION 
Nowadays the resistance of microorganisms to antibacterial drugs is a 
global problem of healthcare1. Due to the increase in cases of diseases 
caused by resistant bacteria, the severity of their treatment, frequent 
mortality, the World Health Organization recommends the development of 
new antimicrobial agents against multidrug-resistant pathogens2. The most 
dangerous are ESKAPE microorganisms, which are characterized by high 
antimicrobial resistance. These include the following microorganisms: 
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp3. 
It is known that derivatives and metabolic products of microorganisms 
are successfully used to combat etiologically significant pathogens of 
diseases separately and together with antibacterial drugs. Scientists have 
shown that the combined antimicrobial use of nisin (product of metabolism 
of Streptococcus lactis) with penicillin / chloramphenicol is effective against 
Staphylococcus aureus SA113 and Staphylococcus pseudintermedius 
DSM21284. The combination of vancomycin / ciprofloxacin against 
resistant and methicillin-susceptible strains of S. aureus3, with polymyxin is 
effective in inhibiting pseudomonas growth4. 
                                                 
1 Trafton А. Probiotics and antibiotics create a killer combination. Delivered together, 
the two join forces to eradicate drug-resistant bacteria. MIT News Office. 2018. URL: 
http://news.mit.edu/2018/probiotics-antibiotics-kill-drug-resistant-bacteria-1017. (дата 
звернення: 17.10.2018) 
2 Geitani R., Moubareck А.С., Touqui L., Sarkis К.D. Cationic antimicrobial peptides: 
alternatives and/or adjuvants to antibiotics active against methicillin-resistant 
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginos. BMC 
Microbiology. 2019. Vol. 19, No 1. P. 54–60. 
3 Field D., O'Connor R., Cotter P.D., Ross R.P., Hill C. In vitro activities of nisin and 
nisin derivatives alone and in combination with antibiotics against Staphylococcus 
biofilms. Frontiers in Microbiology. 2016. Vol. 7. Р. 508–517. 
4 Field D., Seisling N., Cotter P.D., Ross R.P., Hill C. Synergistic nisin-polymyxin 
combinations for the control of Pseudomonas biofilm formation. Frontiers in 
Microbiology. 2016. Vol. 7. Р. 1713–1719. 
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Combinations of actagardine (lantibiotic, produced by Actinoplanes 
brasiliensis) with ramoplanin / metronidazole / vancomycin showed a partially 
synergistic / additive effect to Clostridium difficile5. Lacticin (lacticin 3147 
with Lactococcus lactis) with polymyxin B were effective against S. aureus 
strain6. Plantaricin (product of metabolism of Lactobacillus plantarum) in 
combination with various antibiotics has been shown to be highly effective 
against the microorganism Candida albicans7. The methicillin-resistant strain 
of S. aureus ATCC 700699 was highly sensitive to the combination of 
antimicrobial agents: durancin (durancin 61, produced by Enterococcus 
durans) with vancomycin8. Enterocin CRL35 (producer of Enterococcus 
mundtii CRL35) with tetracycline / erythromycin / chloramphenicol had a 
bactericidal effect on Listeria innocua 7 microorganisms9. 
The widespread use of metabolites of probiotic strains of microorganisms 
is due to their pronounced antimicrobial properties and a wide spectrum of 
action. Today, substances of microbial origin, which are used in scientific and 
research developments to combat antibiotic-resistant microorganisms, as well 
as lantibiotics, which are in clinical and late preclinical trials, are obtained 
using traditional nutrient media. These methods include the cultivation of 
producers on production nutrient media, followed by separation. The cleaning 
stage is time-consuming, requires additional time, equipment and financial 
costs. With this in mind, we have developed a new direction for the production 
of metabolic complexes of probiotic microorganisms with a high level of 
antimicrobial activity without the use of traditional nutrient media7. 
The advantages of this method are simplicity, accessibility, elimination of an 
additional purification step, and a reduction in production time. Along with 
this, the improvement consists in obtaining antimicrobial metabolic complexes 
with more pronounced properties than in production environments due to the 
combination of the effectiveness of structural components (disintegrate) and 
                                                 
5 Mathur H., O’Connor R., Cotter P.D., Ross R.P., Hill C. Analysis of anti-
Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and 
actagardine, both singly and in paired combinations. Antimicrobial Agents and 
Chemotherapy. 2013. Vol. 57. No 6. Р. 2882–2886. 
6 Draper L.A., Cotter P.D., Ross R.P., Hill C. The two peptide lantibiotic lacticin 3147 
acts synergistically with polymyxin to inhibit gram negative bacteria. BMC Microbiology. 
2013. Vol. 13. Р. 212–218. 
7 Sharma A., Srivastava S. Anti-сandida activity of two-peptide bacteriocins, 
plantaricins (Pln E/F and J/K) and their mode of action. Fungal Biology. 2014. Vol. 118. 
No 2. Р. 264–275. 
8 Hanchi H., Hammami R., Gingras Н., Kourda R., Bergeron M.G., Ben Hamida J., 
Ouellette М., Fliss I. Inhibition of MRSA and of Clostridium difficile by durancin 61A: 
synergy with bacteriocins and antibiotics. Future Microbiology. 2017. No 12. Р. 205–212. 
9 Валышев А.В. Комбинация антибиотиков и бактериоцинов – эффективный 
способ борьбы с резистентными микроорганизмами. Бюллетень Оренбургского 
научного центра УрО РАН. 2016. № 4. С. 2–6. URL: http://elmag.uran.ru:9673/ 
magazine/Numbers/2016-4. 
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metabolites10,11. Metabolic complexes obtained by cultivating microbial cells 
of the probiotic strains Lactobacillus rhamnosus GG and Saccharomyces 
boulardii in their own ultrasonic disintegrates showed pronounced activity 
against many antibiotic-resistant opportunistic and pathogenic 
microorganisms. This effectiveness of the combined use of the metabolic 
complexes of bacteria L. rhamnosus GG and S. boulardii, obtained by the 
author, with antibacterial drugs by serial dilution has not been previously 
studied. Work on the determination of changes in minimum inhibitory 
concentrations (MIC) and minimum bactericidal concentrations (MBC) of 
antibiotics in combination with biologically active substances of lactobacilli 
and saccharomycetes was not carried out. The aim of this study was to 
determine the sensitivity of multidrug-resistant strains to antibacterial drugs, 
both independently and in combination with the metabolic complexes of 
bacteria L. rhamnosus GG and S. boulardiifor the possibility of creating on 
their basis, antibiotic “accompaniments-preparations” and antimicrobial agents 
with multifunctional activity. 
 
1. Obtaining biologically active metabolic complexes  
of probiotic strains of microorganisms by author’s method  
without the use of traditional nutrient media 
1.1. Obtaining metabolic complexes of Lactobacillus rhamnosus GG  
and Saccharomyces boulardii by the author’s method 
Microbial cells of Lactobacillus rhamnosus GG (with the symbiotic 
PREEMA®, Schonen, Switzerland) and Saccharomyces boulardii (with the 
probiotic preparation BULARDI®, Schonen, Switzerland) were dissolved in 
0,9% sodium chloride solution, incubated overnight (temperature 37 ± 1°C). 
The microbial mass was washed with a 0,9% sodium chloride solution at 
least three times (1000 g, 30 minutes). 
Disintegrates (structural components) were obtained by irradiation with 
low-frequency ultrasonic waves (generator G3-109) of a suspensions of 
L. rhamnosus GG or S. boulardii (the concentration of which corresponded to 
10,0 units on the McFarland (McF) scale, Densi-La-Meter (PLIVA – Lachema 
Diagnostika, (Czech Republic)). Processing was carried out in an aqueous 
medium in a ring device of the generator in the frequency ranges 
Δf2 = 35 ÷ 50 kHz (fmax = 40,0 kHz) with an excitation amplitude of 
                                                 
10 Спосіб отримання метаболітів пробіотичних штамів бактерій: пат. 123122 
Україна. № 2017 08821; заявл. 04.09.17; опубл. 12.02.18, Бюл. № 3. 4 с. URL: 
http://uapatents.com/7-123122-sposib-oderzhannya-metabolitiv-probiotichnikh-shtamiv-
bakterijj.html. 
11 Спосіб одержання комбінації метаболітів пробіотичних штамів грибів і 
бактерій: пат. 126603 Україна. № 2018 01032; заявл. 02.05.18; опубл. 25.06.18, 
Бюл. № 3. 5 с. 
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U = 15 V at a load of R = 50 Ω (P = 5 W.) The coefficient of conversion of 
electric into acoustic power was ŋ ≈ 5%, that is, the average power the acoustic 
vibrations at the location of biological objects reached (0,25–0,5) W. 
Ultrasonic disintegrates of lactobacilli and saccharomycetes were used to 
cultivate their own microbial cells to obtain metabolic complexes of 
probiotic origin. Suspensions of L. rhamnosus GG or S. boulardii with an 
optical density of 10,0 units on the McF scale (seed is 10% of the total 
volume) were added to the disintegrates. They were cultured under 
microaerophilic conditions for three days (temperature 37 ± 1°C), 
centrifuged (1000 g, 30 minutes), filtered (Vladipor MFAS-B membrane 
filters No. 4, pore diameter 0,2 μm)12. 
Biologically active substances of probiotic microorganisms obtained by 
this method are highly active metabolic complexes free of residues of 
nutrient media. Their pronounced antimicrobial properties are due to the use 
of proprietary probiotic microorganisms’ own ultrasonic disintegrates for 
cultivation. This allowed to increase the level of antimicrobial activity of the 
final product due to a combination of the effectiveness of structural 
components and metabolites of producents13. 
 
1.2. Obtaining a combination of the metabolic complex  
of Lactobacillus rhamnosus GG and Saccharomyces boulardii  
by the author’s method 
The preparation of microbial suspensions of probiotic strains of 
lactobacilli and saccharomycetes and the production of disintegrate 
(structural components) by irradiation with low-frequency ultrasonic waves 
corresponded to the previous method for producing metabolic complexes. 
To obtain a combination of metabolites, a mixture of microbial suspensions 
of L. rhamnosus and S. boulardii (1: 1), with an optical density of 10,0 units 
on the McF scale, was introduced into the lactobacillus disintegrate. Seeds 
accounted for 10% of the total volume. Then the mixture was cultured under 
microaerophilic conditions for three days (temperature 37 ± 1°C), 
centrifuged (1000 g, 30 minutes), filtered (“Vladipor” MFAS-B membrane 
filters No. 4, pore diameter 0,2 μm). 
A new direction has been proposed for the production of combined 
biologically active substances of probiotic strains without the use of 
                                                 
12 Спосіб отримання метаболітів пробіотичних штамів бактерій: пат. 123122 
Україна. № 2017 08821; заявл. 04.09.17; опубл. 12.02.18, Бюл. № 3. 4 с. URL: 
http://uapatents.com/7-123122-sposib-oderzhannya-metabolitiv-probiotichnikh-shtamiv-
bakterijj.html. 
13 Спосіб одержання комбінації метаболітів пробіотичних штамів грибів і 
бактерій: пат. 126603 Україна. № 2018 01032; заявл. 02.05.18; опубл. 25.06.18, 
Бюл. № 3. 5 с. 
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production nutrient media. This method allows the rational use of production 
resources through a combination of successive stages of obtaining structural 
components and metabolic products. The advantage also lies in the 
simplification of the technology of obtaining a combination of metabolites 
due to the joint cultivation of various types of microorganisms. 
This eliminates the multi-stage procedures for the separate production of 
vital products of various probiotic strains, in particular bacteria and fungi, 
due to the combination of various stages in a single process. The combined 
biologically active substances of the microorganisms L. rhamnosus GG and 
S. boulardii have pronounced antimicrobial properties against many 
antibiotic-resistant opportunistic and pathogenic microorganisms. 
The advantage of this combination of the metabolic complex of lactobacilli 
and saccharomycetes is an increase in antidiphtheria activity compared to 
individual metabolic complexes14. 
 
2. Determination of the sensitivity  
of multidrug-resistant bacterial strains to the antibiotic  
as alone or in combination with a metabolic complex 
2.1. Material for determination of MIC and MBC 
of antibacterial drugs as alone or in combination  
with a metabolic complex against multidrug-resistant pathogens 
Three samples of probiotic origin were selected: the metabolic complex 
L. rhamnosus GG, obtained by culturing lactobacilli in their own disintegrate 
(ML), the metabolic complex S. boulardii, obtained by culturing 
saccharomycetes in their own disintegrate (MS) and a combination of the 
metabolic complex L. rhamnosus GG and S. boulardii, obtained by culturing 
co-cultures of lactobacilli and saccharomycetes in lactobacillus disintegrate 
(MLS). Metabolic complexes in the experiment were used in bacteriostatic 
concentrations of selected pathogens 0,01 –0,14 mg / ml of total protein 
determined by the Lowry method15. 
The following test cultures were used for research: resistant strains of 
Pseudomonas aeruginosa PR, Enterococcus faecalis PR, Lelliottia 
amnigena (Enterobacter amnigenus) PR isolated from patients with 
inflammatory and purulent-inflammatory diseases of the respiratory tract. 
Antibiotic-resistant cultures of P. aeruginosa PR (to cefoperazone, 
cefepime, imipenem, meropenem, cefotaxime, ceftriaxone) L. amnigena 
                                                 
14 Ісаєнко О.Ю. Протидифтерійні властивості структурно–метаболітних 
комплексів пробіотичних штамів лактобактерій і сахароміцетів в тестах in vitro та in 
vivo. Фізіологічний журнал. 2019. Т. 65, No 6. С. 51–61. doi: 10.15407/fz65.06.051. 
15 Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with 
the folin phenol reagent. J Biol Chem. 1951. Vol. 193. No 1. Р. 265–275. 
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(E. amnigenus) PR (to ceftriaxone, cefepime, levofloxacin, ampicillin, 
doxycycline, amoksiklav), E. faecalisPR (to gentamicin, ceftriaxone, 
ofloxacin) were taken from the collection of microorganisms of the 
laboratory for the prevention of respiratory infections, SI «I. Mechnikov 
Institute of Microbiology and Immunology of National Academy of Medical 
Sciences of Ukraine». Bacterial suspensions were prepared using 0,9% 
sodium chloride solution. The optical density of the samples corresponded to 
0,5 units on the McFarland scale (Densi-La-Meter device (PLIVA-Lachema 
Diagnostika, Czech Republic)). 
 
2.2. Determination of MIC (inhibitory) antibiotic concentration alone  
or in combination with a metabolic complex 
The sensitivity of the antibiotic-resistant bacterial strains to the test 
substances was determined using the serial dilution micromethod in a liquid 
nutrient medium according to the order16,17. The technique was carried out in 
polystyrene 96-well plates manufactured by EXIMKARGOTREYD LLC 
(Ukraine). Amikacin (amikacin sulfate, Lekhim-Kharkiv) and ciprofloxacin 
(Ananta Medicare, Great Britain) were used as antibacterial drugs.  
The serial dilution method was based on double serial dilutions of 
antibiotics: ciprofloxacin (from 64 mg / ml to 0,03 mg / ml) and amikacin 
(from 1024 mg / ml to 0,5 mg / ml). The experimental samples contained a 
liquid nutrient medium (Muller-Hinton broth), a bacterial suspension of test 
cultures and various concentrations of antibacterial drugs individually or in 
combination with metabolic complexes. Negative control K (-) – nutrient 
medium with test substances (instead of test cultures, 0,9% sodium chloride 
solution was added). Positive control K (+) – nutrient medium with test 
cultures (instead of the test substances, 0,9 % sodium chloride solution was 
added). The optical density of the initial samples was measured (0 hours) 
after incubation at a temperature of (37 ± 1)°C after ~ 22 hours. To establish 
the minimum bactericidal concentration (MBC) the contents of the well were 
inoculated onto a solid nutrient medium (Mueller – Hinton agar). 
The MIC (inhibitory) concentration (MIC) of the antibiotic alone or in 
combination with the metabolic complex was considered the lowest 
concentration that inhibits the growth of multidrug-resistant strains of 
                                                 
16 The European Committee on Antimicrobial Susceptibility Testing. Breakpoint 
tables for interpretation of MICs and zone diameters. Version 9.0. 2019. URL: 
http://www.eucast.org. 
17 Методика визначення та оцінка чутливості мікроорганізмів до антимікробних 
препаратів (заснована на рекомендаціях EUCAST – Європейського комітету з 
визначення чутливості до антимікробних препаратів: наказ Міністерства охорони 
здоров’я України. 2017. URL: ukrbio.com.ua › files › Seminar › EUCAST_UKR_ 
2017_full_UB. 
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microorganisms. The calculation of the results was evaluated visually (complete 
suppression of visible growth) and spectrophotometrically (the optical density of 
the samples was measured using an Lisa Scan EM analyzer (Erba Mannheim, 
Czech Republic) at a wavelength of 630 nm). To calculate the degree of 
inhibition of test cultures by research substances, the formula was used: 
% Inhibition (suppression) = 100 – Оd – Оn 
Оp
×100, 
where: OD – is the optical density of the experimental sample, On – is 
the optical density of the negative control, Op – is the optical density of the 
positive control18. 
Statistical processing of the results was carried out using Microsoft Office 
Excel 2007 and Statistica 10.0 (StatSoft Inc., USA). The experimental data are 
presented as the mean value (x) indicating the standard deviation of the 
arithmetic mean (SD). Statistical comparison between the individual groups 
was performed using one-way analysis of variance (ANOVA) corrected by the 
Bonferroni test. The differences were considered statistically significant when 
the values were * – p <0.05, ** – p <0.01, *** – p <0.001 relative to the 
negative control С (-) and § – p <0.01, # – p <0.001 relative to the positive 
control. The experiment was repeated three times. 
 
3. The results of minimal inhibitory and bactericidal concentrations  
of combination of amikacin or ciprofloxacin with metabolic complexes 
of L. rhamnosus GG and S. boulardii, obtained by the author’s method 
against multirdrug-resistant microorganisms 
The optical density of samples of microorganisms after incubation in the 
studied substances was at the initial level and with indicators of negative control, 
which indicated 100% inhibition of pathogens (Fig. 1 a, b, c, d, e, f, g). When a 
combination of ML with ciprofloxacin (C) was added to the medium, the MIC 
of the latter relative to L. amnigena (E. amnigenus) decreased from 1 mg / ml to 
0,06 mg / ml. The optical density of these samples was 0,07 ± 0,005 (100% 
inhibition) compared with a separate application of the indicated antibiotic 
concentration – the optical density of which was 0,447 ± 0,03 (16,2% inhibition) 
(Fig. 1, a). The combination of bacteriostatic concentrations of C with ML 
(0,02 mg / ml) was accompanied by a significantly larger (p <0,05) decrease in 
the optical density of the samples (0,1562 ± 0,006) relative to samples with 
similar doses of the antibiotic (0,5147 ± 0,03). The degree of growth inhibition 
of L. amnigena (E. amnigenus) was: under the influence of C + ML – 70,7%, 
                                                 
18 Sudagidan M., Yemeniciog˘lu А. Effects of nisin and lysozyme on growth 
inhibition and biofilm formation capacity of Staphylococcus aureus strains isolated from 
raw milk and cheese samples. Journal of Food Protection. 2012. Vol. 75. No 9.  
Р. 1627–1633. 
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and C – 3,5% (p = 0,003). This can be explained by the fact that the addition of 
metabolites to antibiotics with a concentration lower than MIC had a more 
inhibitory effect on the growth of microorganisms. 
 
  
  
  
 
Fig. 1. The MIC value for L. amnigena (E. amnigenus) PR (a, b, c), E. faecalis 
PR (d), P. aeruginosa PR (e, f, g) combinations of amikacin (A) or ciprofloxacin 
(C) with metabolic complex of L. rhamnosus GG (ML) obtained by culturing 
lactobacilli in their own disintegrate (a, d, e), a combination of amikacin or 
ciprofloxacin with the metabolic complex of L. rhamnosus GG and S. boulardii 
(MLS), obtained by culturing co-cultures of lactobacilli and saccharomycetes in 
lactobacillus disintegrate (b, f), a combination of amikacin or ciprofloxacin with 
the metabolic complex of S. boulardii (MS) obtained by cultivation 
saccharomyces in own disintegrate (c, g), negative control С (-) – nutrient 
medium with the studied filtrates, positive control С (+) – nutrient medium  
with test cultures. The optical density data are presented as the average  
of the research and control samples (x ± SD, n = 3) 
Notes: the differences are significant * – p <0,05, ** – p <0,01, *** – p <0,001 
relative to the negative control С (-) and § – p <0,01, # – p <0,001 relative to the 
positive control С (+) 
165 
The strain L. amnigena (E. amnigenus) showed less sensitivity to the 
combined action of ciprofloxacin with MLS and MS: a decrease in the MIC of 
the antibacterial drug from 1 mg / ml to 0,25 mg / ml (p <0,05) was observed 
(Fig. 1, b, с). Under the influence of the indicated concentration of 
ciprofloxacin, growth inhibition of L. amnigena (E. amnigenus) was observed, 
which amounted to 11,9 % (optical density 0,4343 ± 0,02) against 100 % 
inhibition when combined with MS and MLS (0,01 mg / ml) (optical density 
0,07 ± 0,003 (p = 0,001) and 0,075 ± 0,004 (p = 0,001), accordingly).  
A significant inhibition of the multidrug-resistant strain of P. aeruginosa 
was observed with the combined use of MS with ciprofloxacin: the 
bactericidal concentration decreased from 1 mg / ml to 0,12 mg / ml 
(p <0,0002) (Fig. 1, g). At the indicated antibiotic concentration, inhibition 
of pseudomonas growth was accompanied by a decrease in the optical 
density of 0,3498 ± 0,01, and when the antibiotic and MS were combined, it 
was 0,08 ± 0,006 (complete elimination of the pathogen). The MIC of 
ciprofloxacin to P. aeruginosa decreased equally (from 1 mg / ml to  
0,25 mg / ml, p <0,02) when combined with the metabolite complexes ML 
(0,07 mg / ml) or MLS (0,1 mg / ml) (Fig. 1, e, f). The optical densities of 
combinations of ciprofloxacin with ML (0,08 ± 0,006) and MLS  
(0,08 ± 0,004) corresponded to 100% inhibition of growth of this 
pseudomonas strain. The concentration of ciprofloxacin is lower than the 
MIC reduced the optical density of the samples to 0,3498 ± 0,01 (growth 
inhibition – 58,4%), and when combined with ML – 0,1851 ± 0,01 (84,5% 
death of microbial cells), with MLS – 0,1733 ± 0,009 (inhibition –86,5%). 
The data presented show that the MIC value of antimicrobial agents can 
be reduced by using metabolic complexes of lactobacilli and 
saccharomycetes with respect to multidrug-resistant pathogens. The addition 
of metabolites to the bacteriostatic concentration of antibiotics has a high 
inhibitory effect on the growth and reproduction of microbial cells of the 
pathogen, and is manifested by a significantly larger decrease in the optical 
density of test cells compared to the action of a single antibiotic. Therefore, 
when using low concentration antibiotics with metabolic complexes, the 
synergistic antimicrobial activity persists. 
The minimum inhibitory concentration of ciprofloxacin in relation to the 
multidrug-resistant strain of E. faecalis decreased from 4 mg / ml to  
2 mg / ml when combined with ML (0,14 mg / ml) (Fig. 1, d). No changes in 
MIC of amikacin (A) by E. faecalis under the influence of ML were noted. 
However, with the combined use of amikacin with ML, which causes a 
bacteriostatic effect, there was a significant decrease in the optical density 
(0,119 ± 0,007) of enterococcal test cells relative to amikacin  
(0,1584 ± 0,009). These indicators indicate 89,1% and 73,1% inhibition of 
pathogen growth, respectively (p = 0,007). 
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The use of ML with amikacin had a great influence on the growth and 
reproduction of P. aeruginosa microbial cells: the bactericidal concentration 
decreased from 16 mg / ml to 2 mg / ml. The optical density of these 
samples with a metabolic complex was 0.09 ± 0.01, in contrast to the optical 
density without ML 0,4068 ± 0,04 (p = 0,002) (Fig. 1, e). The combination 
of ML (0,07 mg / ml) with amikacin in a concentration below the MIC 
relative to the pathogen under study caused a greater inhibition of the growth 
of pseudomonas microbial cells compared to the action of a single 
antibacterial drug. Thus, the optical density of samples with the highest of 
these concentrations with the relative to pseudomonas strain (0,4615 ± 0,02) 
decreased with the addition of ML (0,1182 ± 0,003) (p = 0,0007). 
Similar antimicrobial activity was observed when amikacin was co-
administered with a combination of the MLS metabolic complex against a 
multidrug-resistant strain of P. aeruginosa (Fig. 1, f). Their combined 
effect reduced the bactericidal concentration of amikacin from 16 mg / ml 
to 2 mg / ml (p = 0,002). It should be noted that the addition of MLS 
(0,1 mg / ml) to all tested different concentrations of antibiotic also led to a 
statistically significantly greater bacteriostatic effect on the selected strain 
of P. aeruginosa than with a single application of the latter (p <0,05). 
These data confirm the results of the combined effects of ML and 
amikacin. The minimum concentration of amikacin required for complete 
inhibition of P. aeruginosa growth decreased from 16 mg / ml to 4 mg / ml 
(p = 0,02) when combined with the metabolic complex of saccharomycetes 
(Fig. 1, g). The minimum bactericidal concentrations (MBC) of 
combinations of antibacterial drugs with metabolic complexes for all 
selected multidrug-resistant strains correspond to their minimum 
inhibitory concentrations. 
 
4. Analysis of susceptibility indicators of multidrug-resistant 
microorganisms to the combined use of antibacterial drugs  
with metabolic complexes of Lactobacillus rhamnosus GG  
and Saccharomyces boulardii, obtained by the author’s methods 
Dependence was found between the antimicrobial effect in a separate test 
of antimicrobial agents and their combine use with metabolic complexes. 
The correlation coefficient between the antibacterial activity of amikacin and 
their combinations with ML against P. aeruginosa is r = 0,7368, p = 0,007. 
A strong correlation for this microorganism was established between the 
degree of inhibition of pathogen growth under the influence of amikacin and 
its combination with MLS (r = 1, р = 0,007) and MS (r = 0,9496, р = 0,007). 
A strict direct correlation for this pathogen was found with a combination of 
ciprofloxacin with MS (r = 1, p = 0,02) in comparison with a separate use of 
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a production drug. A correlation was determined between the bacteriostatic 
concentration of ciprofloxacin compared with its combination with MLS 
(r = 0,968, p = 0,002) and MS (r = 0,73, p = 0,03). A strong negative 
correlation was also observed between the antimicrobial effect of 
bactericidal concentrations of ciprofloxacin, both separately and in 
combination with ML for representatives of L. amnigena (E. amnigenus) 
(r = 1, p = 0,04) and E. faecalis (r = 1, p = 0,002). A strong direct correlation 
between microorganisms L. amnigena (E. amnigenus) (r = 0,999, 
p = 0,0001) and E. faecalis (r = 1, p = 0,002) was formed between 
bacteriostatic concentrations of ciprofloxacin separately and together with 
ML. This indicates that potentiation of metabolic complexes and 
antibacterial drugs occur not only with bactericidal concentrations of the last 
one. With the combined use of metabolic complexes with bacteriostatic 
concentrations of production drugs, a significantly enhanced antimicrobial 
effect is observed. This allows us to conclude that the combined use of 
metabolic complexes with antibiotics, in any case, to a greater extent inhibits 
antibiotic-resistant pathogens in comparison with the individual action of 
the antibiotic. 
The combination of amikacin and ciprofloxacin with ML / MLS / MSC 
showed high antimicrobial activity against P. aeruginosa. Potentiation of 
ciprofloxacin with ML / MLS / MS was detected in relation to L. amnigena 
(E. amnigenus). An increase in the antibacterial effect to E. faecalis was 
observed with a combination of ciprofloxacin with ML (Table 1). A positive 
result is any reduction in the MIC of the drug in combination with the active 
substance (metabolic complex). Diagnostic value is a decrease in the 
inhibitory dose of the antibiotic ≥ 8 times19. 
According to the results of the experiments, it was found that all the 
studied metabolic complexes showed synergistic activity with amikacin or 
ciprofloxacin and reduced their MIС by 4–8 times relative to P. aeruginosa. 
Among them, the greatest joint effect was observed when using amikacin 
with ML and MLS, and ciprofloxacin with MS. The maximum combined 
antimicrobial activity was observed when testing ciprofloxacin with ML to 
L. amnigena (E. amnigenus): the concentration of the drug decreased by 
16 times. And when it is combined with MLS or MS to the same 
microorganism, the bactericidal concentration decreased four times. 
The smallest effect (2 times) was obtained with the simultaneous use of 
ciprofloxacin with ML in relation to E. faecalis. 
                                                 
19 EUCAST guidelines for detection of resistance mechanisms and specific resistances of 
clinical and/or epidemiological importance. EUCAST. Version 2.0. 2017. URL: 
https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_ 
mechanisms/EUCAST_detection_of_resistance_mechanisms_170711.pdf. 
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Table 1 
Changes the MIC of antibacterial drugs when used in combination  
with metabolic complexes of Lactobacillus rhamnosus GG  
and Saccharomyces boulardii, obtained by the author’s methods  
for multidrug-resistant microorganisms (method of serial dilutions) (n = 3) 
Antibacterial 
drugs 
Multidrug-resistant microorganisms 
P. aeruginosa L. amnigena  (E. amnigenus) E. faecalis 
metabolic complexes of L. rhamnosus GG  
and S. boulardii 
M
L 
M
L
S 
M
S 
M
L 
M
L
S 
M
S 
M
L 
M
L
S 
M
S 
Amikacin 8 8 4 - - - - - - 
Ciprofloxacin 4 4 8 16 4 4 2 - - 
Note: ML is the metabolic complex of L. rhamnosus GG obtained by cultivation of 
lactobacilli in its own disintegrates, MLS is the combination of the metabolic complex of 
saccharomycetes and lactobacilli, obtained by cultivation of joint cultures of lactobacilli 
and saccharomycetes in the disintegrate of lactobacilli, MS is the metabolic complex of 
S. boulardii obtained by cultivation of saccharomycetes in its own disintegrates; 2–16 – 
synergistic effect (a decrease in the number of MIC of an antibacterial drug) – there is no 
synergistic effect (a decrease in MIC of an antibacterial drug was not observed). 
 
Thus, changes in the MIC of antibacterial drugs in combination with the 
metabolic complexes of L. rhamnosus GG and S. boulardii, obtained by 
culturing producents in the disintegrate of probiotic microorganisms that 
suppressed the growth of multidrug-resistant test cultures, occurred in 
relation to different bacteria to varying degrees. Experimental studies of the 
combined effects of metabolic complexes with antibacterial drugs have 
shown that the effectiveness of synergistic action depends on the antibiotic 
and the sensitivity of test cultures to experimental combinations. 
 
5. Assessment of the sensitivity of multidrug-resistant microorganisms 
to the combined action of antibacterial drugs with the metabolic 
complexes Lactobacillus rhamnosus GG and Saccharomyces boulardii 
obtained by the author’s methods 
According to preliminary results, antibacterial drugs with metabolites 
showed a high level of synergistic activity20. Amikacin and ciprofloxacin 
                                                 
20O.Y. Isayenko, O.V. Knysh, O.V. Kotsar, T.N. Ryzhkova, G.I. Dyukareva, Simultaneous 
and sequential influence of metabolite complexes of Lactobacillus rhamnosus and 
Saccharomyces boulardii and antibiotics against poly-resistant Gram-negative 
bacteria. Regulatory Mechanisms in Biosystems. 2020. Vol 11. No 1. Р. 139–145. 
DOI: https://doi.org/10.15421/022021/  
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were selected according to two criteria. Firstly, they belong to different 
groups of antibacterial drugs. These antimicrobial agents have a different 
mechanism of action on microbial cells of pathogens. Aminoglycosides 
(amikacin) – block protein synthesis and destroy the cytoplasmic 
membranes of bacteria, fluoroquinolones (ciprofloxacin) – disrupt DNA 
synthesis in bacterial cells. Secondly, the selected antibiotics attract 
attention because they can be used to treat infectious skin diseases21. 
The study allowed us to determine not only the degree of suppression of 
pathogens depending on the concentration of research combinations, but 
also to establish the effectiveness of the combined use of metabolite 
complexes with antibacterial drugs that cause various damage to microbial 
cells of etiologically significant pathogens. The results showed that the 
effectiveness of the antimicrobial combined effect does not depend on the 
mechanism of action of the antibiotic on microbial cells of pathogens. 
Reducing the therapeutic dose of antibacterial drugs, while not reducing 
the effectiveness of treatment, is important. Of special actuality is the 
above with respect to drugs with severe toxicity, in particular 
aminoglycosides. 
The results of the combined use of the metabolic complexes of 
L. rhamnosus GG and S. boulardii with antibacterial drugs are shown to 
have a synergistic effect, which was manifested by potentiation (substances 
enhance the antimicrobial effect of each other) or indifferent effect (the 
effect of one substance does not depend on the presence of the other) for 
both antibiotics. The antimicrobial combined effect was accompanied by the 
following changes. The strain of L. amnigena (E. amnigenus) showed even 
greater sensitivity to the combined use of an antibacterial drug with the 
metabolic complex ML (a 16-fold decrease in MIC was noted). The data 
presented have important scientific and practical value, based on the 
following. Firstly, some representatives of Enterobacteriaceae, in particular 
E. aerogenes, have polyresistance to fluoroquinolones, beta-lactams, and 
other antibiotics. The evidence obtained can solve this problem through the 
introduction of innovative therapeutic approaches to combat antibiotic-
resistant pathogens. Secondly, due to a metagenomic analysis of 
pathological material obtained from patients with purulent wounds, an 
overwhelming amount of DNA was found representatives of the family 
Clostridiaceae and Enterobactericeae. It was difficult to isolate these 
pathogens during bacteriological studies (S. aureus was isolated 
                                                 
21 Галимзянов Ф.В. Лечение инфицированных ран и раневой инфекции : учебное 
пособие. Екатеринбург: УГМА, 2012.88 с. URL: https://docplayer.ru/ 
30252647-Lechenie-inficirovannyh-ran-i-ranevoy-infekcii.html. 
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predominantly) 22,23. These results prove the potential for constructing based 
on metabolic complexes of lactobacilli and saccharomycetes of 
“accompaniments-preparations” to antibiotics for the treatment of wound 
infections24,25,26. Resistant to ciprofloxacin E. faecalis showed moderate 
resistance to the combined use of the antibiotic with the metabolite complex 
ML, despite a decrease in MIC by only half.  
 
CONCLUSIONS 
The results of combined using of metabolites L. rhamnosusGG and 
S. boulardii with antibiotics show synergetic activity which manifested 
potential and indifferent actions. Metabolic complexes demonstrate a 
potentiation with antibiotics with different mechanism of action. 
An intensity of changes depends from concentration of antibacterial drugs 
and individual sensitivity of test-strains. An increased antimicrobial activity 
was observed for four combinations ML with such antibiotics (against 
Р. аеruginosa – amikacin or ciprofloxacin, against L. amnigena 
(E. amnigenus) and E. faecalis – ciprofloxacin); with MLS and MS – for 
three combinations (against Р. аеruginosa – amikacin or ciprofloxacin, 
against L. amnigena (E. amnigenus) – ciprofloxacin). Expressed potentiation 
was established by using of combination ML or MLS with amikacin and MS 
with ciprofloxacin against Р. аеruginosa. MIC of these antibiotics decreased 
by 8 times. The largest decrease of MIC (by 16 times) was received by 
                                                 
22 Щуплова Е.А., Фадеев С.Б. Изучение видового состава микрофлоры очагов 
гнойно-воспалительных процессов с использованием разных методических 
подходов. Бюллетень Оренбургского научного центра УрО РАН. 2016. № 2. URL: 
https://cyberleninka.ru/article/n/izuchenie-vidovogo-sostava-mikroflory-ochagov-gnoyno-
vospalitelnyh-protsessov-s-ispolzovaniem-raznyh-metodicheskih-podhodov. 
23 Тец Г.В., Тец В.В., Ворошилова Т.М., Смирнова Е.И., Кардава К.М., Кара-
мян Т.А., Заславская Н.В., Викина Д.С., Зайцева М.А., Артеменко К.Л., Вечерков-
ская М.Ф. Кауфман А.С. Выбор антибиотика в микробиологическом исследовании 
гнойно-воспалительных процессов. Клиническая лабораторная диагностика. 2017. 
Т. 62, № 6. С. 372–375. doi: htpp://dx.doi.org/10.18821/0869-2084-2017-62-6-372-375. 
24 Isayenko O.Y., Knysh, O.V., Kotsar, O.V. Ryzhkova T.N. Dyukareva, G.I. 
Simultaneous and sequential influence of metabolite complexes of Lactobacillus 
rhamnosus and Saccharomyces boulardii and antibiotics against poly-resistant Gram-
negative bacteria. Regulatory Mechanisms in Biosystems. 2020. Vol 11. No 1. Р. 139–145. 
doi: https://doi.org/10.15421/022021. 
25 Isayenko, O., Knysh, O., Kotsar, O., Ryzhkova, T., Dyukareva, G. Evaluation of 
anti-microbial activity of filtrates of Lactobacillus rhamnosus and Saccharomyces 
boulardii against antibiotic-resistant gram-negative bacteria. Regulatory Mechanisms in 
Biosystems. 2019. Vol. 10. № 2. Р. 245–250. doi: 10.15421/021937. 
26 Isayenko, O.Y., Knysh, O.V., Babych, Y.M., Ryzhkova, T.N., Dyukareva, G.I. 
Effect of disintegrates and metabolites of Lactobacillus rhamnosus and Saccharomyces 
boulardii on biofilms of antibiotic resistant conditionally pathogenic and pathogenic 
bacteria. Regulatory Mechanisms in Biosystems. 2019. Vol 10. № 1. Р 3–8. doi: 
10.15421/021901. 
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combination ML with ciprofloxacin to L. amnigena (E. amnigenus). Due to 
the proven effective combined antimicrobial activity of the studied 
substances of lactobacilli and saccharomycetes with antibacterial drugs, it is 
possible to reduce the therapeutic concentration of the antibiotic, shorten the 
period of its use, and slow down the likelihood of developing chronic 
diseases. Thus, the metabolite complexes obtained by the author’s methods 
are promising for development, “accompaniments-preparations” for new 
generation antimicrobials. 
 
SUMMARY 
Nowadays the resistance of microorganisms to antibacterial drugs is a 
global problem healthcare. In this work, the sensitivity of multidrug-resistant 
strains (Pseudomonas aeruginosa, Enterococcus faecalis, Lelliottia 
amnigena (Enterobacter amnigenus) was determined, both separately and in 
combination with the metabolic complexes Lactobacillus rhamnosus GG 
and Saccharomyces boulardii, obtained by culturing microbial cells in the 
disintegrate of probiotic microorganisms. The advantages of the new 
direction of obtaining metabolic complexes with pronounced antimicrobial 
properties in relation to many antibiotic-resistant opportunistic and 
pathogenic microorganisms are simplicity, accessibility, elimination of an 
additional stage of purification from traditional nutrient media, shortened 
production time, increased antibacterial activity due to the combination of 
the effectiveness of disintegrates and metabolites. Potentiation of the 
antibacterial action of the metabolic complexes of L. rhamnosus GG and 
S. boulardii with various mechanisms of antibacterial drugs has been 
established. The intensity of the changes depends on the concentration of 
antibacterial drugs and the individual sensitivity of the test culture of the 
pathogen. Potentiation was established by the combined interaction of 
metabolic complexes with ciprofloxacin, amikacin. The proof of this fact 
was the decrease of MIC by 8–16 times. Due to the proven effective 
combined antimicrobial activity of the metabolites of lactobacilli and 
saccharomycetes with antibacterial drugs, it is possible to reduce the 
therapeutic concentration of the antibiotic, shorten the period of its use, and 
slow down the likelihood of developing chronic diseases. Metabolic 
complexes are promising “accompaniments-preparations” for the treatment 
of infectious diseases caused by multidrug-resistant strains. 
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